Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Bausch & Lomb Incorporated
FDA Inspection
•Bausch & Lomb Incorporated•May 26, 2017

Bausch & Lomb Incorporated – FDA Inspection, May 26, 2017

Record Details

This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on May 26, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Bausch & Lomb Incorporated
Inspection Date
May 26, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Ileana Barreto-Pettit (Issuing Officer)
  • Jennifer L. Huntington (FDA Associated Person)
  • Ruo H. Xu (Issuing Officer)
  • Wendy G. Tan
View Company Profile

ID · 8c2f6020-98e3-45a1-8605-82a171aada39

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1015001
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

11
  1. 21 CFR 211.103Actual vs. theoretical yields not determined
  2. 21 CFR 211.113(a)Procedures for non-sterile drug products
  3. 21 CFR 211.113(b)Procedures for sterile drug products
  4. 21 CFR 211.160(a)Deviations from laboratory control requirements
  5. 21 CFR 211.160(b)Scientifically sound laboratory controls
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.194(a)(1)Description and Identification of Samples
  8. 21 CFR 211.198(a)Complaint Handling Procedure
  9. 21 CFR 211.42(c)(10)(iii)Air Supply
  10. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Bausch & Lomb Incorporated

10
DateClassificationOfficeProject area
March 20, 2026Not classifiedFlorida District Office
August 25, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 30, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 10, 2018OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 25, 2016OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for Bausch & Lomb Incorporated
  • FDA Inspection 1304548 - 2026-03-20
  • FDA Inspection 1218198 - 2023-08-25
  • FDA Inspection 1082137 - 2019-01-30
  • FDA Inspection 1061913 - 2018-08-10
  • FDA Inspection 967714 - 2016-02-25

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bausch & Lomb Incorporated
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.